ArticleJournal of clinical medicine2024

Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled Trial.

Miodrag Janić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.